Cargando…

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)

OBJECTIVE: To investigate the efficacy and safety of rituximab + LEF in patients with RA. METHODS: In this investigator-initiated, randomized, double-blind, placebo-controlled phase 3 trial, patients with an inadequate response to LEF who had failed one or more DMARD were randomly assigned 2:1 to i....

Descripción completa

Detalles Bibliográficos
Autores principales:	Behrens, Frank, Koehm, Michaela, Rossmanith, Tanja, Alten, Rieke, Aringer, Martin, Backhaus, Marina, Burmester, Gerd R, Feist, Eugen, Herrmann, Eva, Kellner, Herbert, Krueger, Klaus, Lehn, Annette, Müller-Ladner, Ulf, Rubbert-Roth, Andrea, Tony, Hans-Peter, Wassenberg, Siegfried, Burkhardt, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566251/ https://www.ncbi.nlm.nih.gov/pubmed/33738492 http://dx.doi.org/10.1093/rheumatology/keab153

Ejemplares similares

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
por: Koehm, Michaela, et al.
Publicado: (2022)

Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up
por: Koehm, Michaela, et al.
Publicado: (2022)

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting
por: Alten, Rieke, et al.
Publicado: (2018)

Ignatia Amara
Publicado: (1891)

Hélder C{circ}amara /
por: Schilling, Paulo R.
Publicado: (1969)

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients
por: Wendler, Joerg, et al.
Publicado: (2014)

Leflunomide/rituximab: SARS-CoV-2 infection: case report
Publicado: (2021)

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
por: Burmester, Gerd R, et al.
Publicado: (2010)

Amarás a dios sobre todas las cosas
por: Hernández, Alejandro, 1958-

A new species of Amara (Coleoptera, Carabidae, Zabrini) from Sichuan Province, China, with additional records for other Amara species from the region
por: Hieke, Fritz, et al.
Publicado: (2012)

Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria
por: Iking-Konert, Christof, et al.
Publicado: (2011)

Gunshot Wounds in the Bengal Stationary Hospital, Amara, 1915-1916
por: Nott, A. H.
Publicado: (1917)

An Independent Evolutionary Origin for Insect Deterrent Cucurbitacins in Iberis amara
por: Dong, Lemeng, et al.
Publicado: (2021)

Evaluation of some pharmacological activities of Budmunchiamine - A isolated from Albizia amara
por: Thippeswamy, Sreerangegowda, et al.
Publicado: (2015)

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
por: Kellner, Herbert, et al.
Publicado: (2010)

Differential transcriptome analysis reveals insight into monosymmetric corolla development of the crucifer Iberis amara
por: Busch, Andrea, et al.
Publicado: (2014)

The Mitochondrial Genome of Amara aulica (Coleoptera, Carabidae, Harpalinae) and Insights into the Phylogeny of Ground Beetles
por: Li, Zhenya, et al.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Iberis amara Extract Induces Intracellular Formation of Reactive Oxygen Species and Inhibits Colon Cancer
por: Weidner, Christopher, et al.
Publicado: (2016)

Survey of Knowledge, Attitudes and Practice of the Elderly toward COVID-19 Pandemic in Al-Amara, Iraq
por: Al-Abedi, G.
Publicado: (2022)

Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
por: Krüger, Klaus, et al.
Publicado: (2020)

Leflunomide leads to inhibition of transendothelial migration
por: Grisar, J, et al.
Publicado: (2001)

Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies
por: Genovese, Mark C, et al.
Publicado: (2020)

Biologicals in rheumatoid arthritis: current and future
por: Avci, Ali Berkant, et al.
Publicado: (2015)

The role of upadacitinib in the treatment of moderate-to-severe active rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
por: Tony, Hans-Peter, et al.
Publicado: (2011)

Immediate determination of ACPA and rheumatoid factor - a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay
por: Renger, Franziska, et al.
Publicado: (2010)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
por: Lindenberg, Luisa, et al.
Publicado: (2015)

Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities
por: Koehm, Michaela, et al.
Publicado: (2023)

A DNA barcode library for ground beetles of Germany: the genus Amara Bonelli, 1810 (Insecta, Coleoptera, Carabidae)
por: Raupach, Michael J., et al.
Publicado: (2018)

Use of leflunomide in patients with chronic hypersensitivity pneumonitis
por: Noh, Sungryong, et al.
Publicado: (2020)

8. Myositis as an idiosyncratic drug reaction to leflunomide
por: Darren, Angeline, et al.
Publicado: (2019)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis
por: Behrens, Frank, et al.
Publicado: (2016)

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

Automated evaluation of ANA under real-life conditions
por: Loock, Clemens Dario, et al.
Publicado: (2017)

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis
por: Emery, Paul, et al.
Publicado: (2011)

Antihyperlipidemic potential of Albizia amara (Roxb) Boiv. bark against Triton X-100 induced hyperlipidemic condition in rats
por: Gundamaraju, Rohit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1obkqv4ugf222m71fjn22snp8o